This first book in a romantasy duology by TikTok star Sasha E. Sloan combines a compelling love triangle, luscious ...

Lyra Therapeutics (LYRA), announced that its Board of Directors has decided to suspend further development of LYR-210, the Company’s lead product candidate for the treatment of chronic rhinosinusitis.

The Northrop Grumman Cygnus cargo spacecraft was captured by the International Space Station's robotic arm. Credit: NASA Department of Labor under fire for language similar to Nazi slogan Device that ...

Lyra Therapeutics is abandoning work on its rhinosinusitis treatment and laying off its remaining employees. The Massachusetts-based biotech had been working on LYR-210 for chronic rhinosinusitis (CRS ...

Lyra Health, a mental health company, announced Monday that it is expanding its substance use disorder services to support those struggling with cannabis, stimulants, opioids and nicotine. Burlingame, ...

Lyra Therapeutics is suspending further development of its lead product candidate for the treatment of chronic rhinosinusitis and taking steps to cut costs, including workforce reductions that will ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min After a failed clinical trial in ...

Jupiter continues shining brightly in the east in the evening among the stars of Gemini. To the right of Gemini is Orion with orange-red Betelgeuse and blue-white Rigel at diagonally ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.